1. Home
  2. HGBL vs ESLA Comparison

HGBL vs ESLA Comparison

Compare HGBL & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Heritage Global Inc.

HGBL

Heritage Global Inc.

HOLD

Current Price

$1.24

Market Cap

42.0M

ML Signal

HOLD

Logo Estrella Immunopharma Inc.

ESLA

Estrella Immunopharma Inc.

HOLD

Current Price

$0.97

Market Cap

45.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HGBL
ESLA
Founded
1937
2021
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
42.0M
45.6M
IPO Year
1998
N/A

Fundamental Metrics

Financial Performance
Metric
HGBL
ESLA
Price
$1.24
$0.97
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
1
Target Price
$3.85
$8.00
AVG Volume (30 Days)
92.0K
43.0K
Earning Date
05-07-2026
05-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.02
N/A
Revenue
$20,129,000.00
N/A
Revenue This Year
$11.92
N/A
Revenue Next Year
$13.52
N/A
P/E Ratio
$61.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.13
$0.78
52 Week High
$2.32
$3.15

Technical Indicators

Market Signals
Indicator
HGBL
ESLA
Relative Strength Index (RSI) 43.85 41.07
Support Level $1.20 $0.97
Resistance Level $1.45 $1.28
Average True Range (ATR) 0.04 0.08
MACD -0.00 0.01
Stochastic Oscillator 25.06 39.29

Price Performance

Historical Comparison
HGBL
ESLA

About HGBL Heritage Global Inc.

Heritage Global Inc values and monetizes industrial and financial assets by providing acquisition, disposition, valuation, and lending services for surplus and distressed assets. It operates in four segments. The Auction and Liquidation segment, which operates as a full-service auction, appraisal, and asset advisory firm, includes the acquisition of turnkey manufacturing facilities and used industrial machinery and equipment. The Refurbishment & Resale segment acquires, refurbishes, and supplies specialized laboratory equipment. Brokerage segment, through NLEX, brokers charged-off receivables in the U.S. and Canada on behalf of financial institutions. The Specialty Lending segment, which provides specialty financing solutions to investors in charged-off and nonperforming asset portfolios.

About ESLA Estrella Immunopharma Inc.

Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.

Share on Social Networks: